Invitation to Targovax’s third quarter 2022 presentation, Thursday 3 November

On October 26, 2022 Targovax ASA (OSE: TRVX) reported that it will announce its third quarter 2022 results on Thursday 3 November 2022 (Press release, Targovax, OCT 26, 2022, View Source [SID1234622390]). Targovax’s management will present the results at a live streamed webcast at 10:00 am CET to investors, analysts and the press.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 am CET, on 3 November 2022.

Presentation
There will be a virtual presentation of the results with a live webcast 3 November at 10.00 am CET. You can join the webcast here. It will be possible to ask questions during the presentation

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!